美年健康
(002044)
| 流通市值：171.14亿 | | | 总市值：173.01亿 |
| 流通股本：38.72亿 | | | 总股本：39.14亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,801,337,075.22 | 10,893,535,007.49 | 7,217,331,650.49 | 4,405,411,317.91 |
| 营业收入 | 1,801,337,075.22 | 10,893,535,007.49 | 7,217,331,650.49 | 4,405,411,317.91 |
| 二、营业总成本 | 2,107,445,751.54 | 9,995,374,869.11 | 6,831,154,198.18 | 4,364,142,856.17 |
| 营业成本 | 1,296,222,659.5 | 6,232,314,171.75 | 4,342,226,166.45 | 2,768,833,315.3 |
| 税金及附加 | 1,046,807.78 | 6,484,387.86 | 2,831,869.02 | 2,097,463.28 |
| 销售费用 | 512,924,249.21 | 2,562,904,527.26 | 1,651,969,466.69 | 1,054,536,011.08 |
| 管理费用 | 209,582,749.67 | 831,999,131.98 | 577,153,870.14 | 374,022,617.99 |
| 研发费用 | 13,166,822.94 | 62,649,103.69 | 41,614,528.18 | 26,511,668.41 |
| 财务费用 | 74,502,462.44 | 299,023,546.57 | 215,358,297.7 | 138,141,780.11 |
| 其中:利息费用 | 77,829,061.98 | 303,676,769.47 | 219,224,654.15 | 141,491,808.42 |
| 其中:利息收入 | 4,965,522.91 | 14,053,986.4 | 10,458,219.6 | 8,011,924.93 |
| 加:公允价值变动收益 | 1,031,655.09 | 41,902,536.02 | -6,378,990.62 | -1,933,339.97 |
| 加:投资收益 | -8,298,436.14 | 7,577,768.84 | -8,275,796.77 | -6,157,021.43 |
| 资产处置收益 | -492,740.5 | -6,894,558.26 | -3,162,592.54 | -2,490,655.61 |
| 资产减值损失(新) | -237,756.13 | -88,787,158.43 | -1,441,894.19 | -685,618.84 |
| 信用减值损失(新) | -23,816,348.92 | 8,518,225.96 | -18,198,902.85 | 14,442,812.64 |
| 其他收益 | 6,296,773.4 | 23,228,446.87 | 9,829,023.42 | 7,485,819.37 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -331,625,529.52 | 883,705,399.38 | 358,548,298.76 | 51,930,457.9 |
| 加:营业外收入 | 1,686,245.31 | 5,690,171.93 | 7,585,903.4 | 5,071,661.5 |
| 减:营业外支出 | 4,712,134.83 | 41,340,248.09 | 14,163,161.69 | 8,328,139.62 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -334,651,419.04 | 848,055,323.22 | 351,971,040.47 | 48,673,979.78 |
| 减:所得税费用 | -25,336,918.85 | 179,231,846.79 | 41,939,227.02 | -6,396,422.27 |
| 六、净利润 | -309,314,500.19 | 668,823,476.43 | 310,031,813.45 | 55,070,402.05 |
| 持续经营净利润 | -309,314,500.19 | 668,823,476.43 | 310,031,813.45 | 55,070,402.05 |
| 归属于母公司股东的净利润 | -286,618,131.63 | 505,621,135.98 | 225,595,778.13 | 10,144,667.02 |
| 少数股东损益 | -22,696,368.56 | 163,202,340.45 | 84,436,035.32 | 44,925,735.03 |
| (一)基本每股收益 | -0.07 | 0.13 | 0.06 | 0 |
| (二)稀释每股收益 | -0.07 | 0.13 | 0.06 | 0 |
| 八、其他综合收益 | -379,156.94 | 231,195.48 | 350,710.14 | 485,520.41 |
| 归属于母公司股东的其他综合收益 | -384,750.24 | 121,362.31 | 147,002.82 | 243,320.31 |
| 九、综合收益总额 | -309,693,657.13 | 669,054,671.91 | 310,382,523.59 | 55,555,922.46 |
| 归属于母公司股东的综合收益总额 | -287,002,881.87 | 505,742,498.29 | 225,742,780.95 | 10,387,987.33 |
| 归属于少数股东的综合收益总额 | -22,690,775.26 | 163,312,173.62 | 84,639,742.64 | 45,167,935.13 |
| 公告日期 | 2024-04-30 | 2024-04-25 | 2023-10-31 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |